Role of humoral mediators in adult respiratory distress syndrome.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D002634:Chemotaxis, Leukocyte; D002867:Chromones / Q000627:therapeutic use; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007249:Inflammation; D007650:Ketanserin; D007958:Leukocyte Count; D007962:Leukocytes / Q000201:enzymology / Q000502:physiology; D008168:Lung / Q000473:pathology; D010880:Piperidines / Q000627:therapeutic use; D010972:Platelet Activating Factor / Q000502:physiology; D011655:Pulmonary Embolism / Q000150:complications; D012128:Respiratory Distress Syndrome / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D013189:SRS-A / Q000037:antagonists & inhibitors / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D012702:Serotonin Antagonists / Q000627:therapeutic use; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors
D001095:Arachidonic Acids; D002867:Chromones; D010880:Piperidines; D010972:Platelet Activating Factor; D013189:SRS-A; D012702:Serotonin Antagonists; D012701:Serotonin; D013928:Thromboxane A2; C006312:FPL 55712; D007650:Ketanserin